If you fancy yourself a psychonaut, or at the very least, have higher than entry-level experience with psychedelics, you’ve probably heard about the dangers of getting arrested with acid. Most psychedelic drug dealers will tell you that they have no problem selling mushrooms, ecstasy, ketamine, or other substances, but only the brave are willing to deal in LSD. Is it worse to get caught with LSD than with other drugs? And if so, why is that? Let’s take a closer look. Getting caught with LSD – federal regulationsThere are a few different ways that people can be charged for LSD-related crimes: possession, trafficking, distribution, simple possession, or intoxication in cases where a drug test is administered. Regarding that last part, there are no mainstream drug tests that can detect LSD, however, there are specific tests that can check for LSD use about 15 to 28 hours after use. These are often used by probation officers and employers, but it’s unlikely that someone would choose to trip balls with an important engagement so soon after. That being said, the majority of LSD charges are for trafficking and distribution. According to the DEA, these are the following minimums for dealing LSD:
These mandatory minimums are the same for most harder drugs regardless of the schedule, including methamphetamine and cocaine which are a schedule II, and heroin which is a schedule I (just like LSD, but with a MUCH higher body count, quite ironic). Where the law differs, is in the amount a person is caught with. For example, to get a federal tracking charge for heroin, you would need to be caught with 100-999 grams (mixture). With Fentanyl, which is up to 50 times more potent than heroin, you would need to have 40-399 grams (mixture) before you get slapped with a tracking charge. When it comes to LSD, a mere 1-9 grams (mixture) would result in the same charges. It’s insane to think that having as little as one gram of acid, a substance that is nearly impossible to overdose on, is treated the same as almost 1000 grams of heroin. As if that’s not bad enough, here’s where things get even more dicey. The key is in the word “mixture”. As per sentencing rules, the mandatory minimums dished out for drug trafficking are based on the “mixture or substance containing a detectable amount” of the drug in question. So, the more the mixture weighs, the longer the prison term will be. It’s done this way because to prevent dealers from getting shorter sentences when their drugs are diluted with cutting agents. The government likes to call this a “market approach” to the war on drugs. Why the “market approach” does not work in LSD cases![]() It makes sense in some situations, but not at all in cases involving LSD. Because LSD is dropped or sprayed on paper, sugar cubes, gelatin, and other carriers in order to be consumed, the weight of the mixture is significantly greater than the weight that the pure substance would be. It’s a much more exaggerated difference than heroin or meth that’s cut with something. But the government does not care how illogical and unjust this is, the paper and sugar cubes are considered part of the LSD “mixture”. A perfect example of this is the case of Stanley Marshall, a 30-year-old man from El Paso, Texas, who was arrested in June of 1988 and charged with “leading a conspiracy to distribute LSD”. The total amount of LSD he was caught with was less than half a gram, but because the carrier paper weighed 113 grams, he was charged for 113.3 grams of LSD “mixture”. Had sentencing guidelines allowed him to be charged for the weight of the pure LSD, he would have spent three years or less in prison. But since the paper weighed over 100 grams, he was sentenced to 20 years. On the flip side, if someone happens to get caught with liquid LSD – which is much more concentrated and almost a guarantee that the person is selling because most consumers don’t have vials of pure, liquid LSD – they benefit from the weight/mixture sentencing laws. So consumers or people who are selling small amounts of the drug will likely end up with much longer sentences than people who might actually be trafficking LSD. Thank you for coming by. Subscribe to the Cannadelics Sunday Edition for email updates; and for sweet offers on tons of swag like cannabis flower, vapes and other smoking-related equipment, edibles, cannabinoids, amanita mushroom extracts, and so much more. We promote feeling good. Come do it! And that’s how completely a** backwards our government is. They do acknowledge this obvious design flaw, yet more than 3 decades later they have yet to change it in any official capacity; although some judges might start to take a bit of leniency in LSD cases as we head into a second, and much more publicized, psychedelic renaissance. The Drug Abuse Act of 1986The Anti-Drug Abuse Act of 1986, a series of laws passed by congress and signed by President Ronald Regan, was a fundamental part of the war on drugs. Among many other things, one of the biggest issues with this bill is that it changed the process of dealing with drug offenders and those released from prison from a rehabilitative system to a punitive system. H.R. 5484 also introduced new mandatory minimums, especially in cases involving crack cocaine. The bill required judges to sentence offender to at least five years’ imprisonment for the possession of only five grams of crack cocaine. However, someone would need to be caught with 500 grams of powder cocaine to receive the same five-year sentence. From a scientific standpoint, crack and powder cocaine are nearly identical. There are no noted pharmacological or chemical differences, and the effects are very similar. The only difference is in the way the drugs are taken (powder is usually snorted whereas crack is smoked). Another difference? Powder was used mainly by white Americans, and crack was largely used by black Americans. Again, same drug… just with a different delivery method and user base. But due to sentencing disparities between crack and powder cocaine, black Americans faced disproportionate punishment with long, discriminatory prison sentences and stricter policing throughout their communities. Mandatory minimums, which started to emerge in the late 1970s, require judges to impose a prison sentence of at least the minimum amount of time specified in a statute. Interestingly, a judge can use their discretion to impose longer terms, but not to offer shorter ones. Today, mandatory minimums are commonly used in federal courts, especially in drug cases. In fact, recent studies show that mandatory minimums are used in more than half of all federal criminal cases to this day. Final thoughtsAlthough I started off thinking this acid thing was an urban drug myth that stuck around since the 70s when drug crimes were more severely penalized in general, I realized that even today, getting caught with LSD is much worse than other drugs. Perhaps this is something we should focus on as we dive into psychedelic reform and reassess the benefits of hallucinogenic drugs. Welcome readers! Thanks for hanging out with us at Cannadelics.com; an independent publication that brings you new and ongoing stories in the cannabis and hallucinogen spaces. Come ’round regularly so you don’t miss out on anything; and subscribe to our Cannadelics Weekly Newsletter, to ensure you’re never late to get the news. The post Is It Worse to Get Caught with LSD Than Other Drugs? appeared first on Cannadelics. Via https://cannadelics.com/2023/05/08/is-it-worse-to-get-caught-with-lsd-than-other-drugs/
0 Comments
Looking for a strong hemp-derived cannabis concentrate that packs a punch? Look no further than THC-A diamonds. With a THC-A content of 99.9% or higher, these crystals are one of the most potent hemp-derived cannabis products on the market. And as part of our Deal of the Day, you can now try THC-A diamonds at unbeatable prices. But what exactly are these diamonds, and why are they so popular among cannabis enthusiasts? In this article, we’ll take a closer look at the new product and explore some of the key topics related to this high-potency cannabis concentrate. Tip: As part of our Deal Of The Day, you can get premium products at the best price per gram, in a range of sizes. The best offer is when you choose the 14g bucket option. Be sure to look for that option! ![]() 99.9% THC-A Diamonds: The Next Level of Cannabis ConcentratesLooking to enhance your cannabis experience with a highly potent concentrate? THC-A diamonds may be just what you’re looking for. What are THC-A Diamonds?THC-A diamonds are a type of hemp-derived cannabis concentrate that is made using fresh high-THCA hemp flower and a hydrocarbon extraction method. The resulting product is a pure, potent crystalline substance that is free from any additives or contaminants. The diamonds get their name from their appearance, which resembles small, glittering diamonds. The Differences Between THC and THC-AWhile THC (AKA Delta-9 THC or Delta-9) and THC-A are chemically similar, they have some important differences. THC is the psychoactive compound in cannabis that produces a potent high, while THC-A (Tetrahydrocannabinolic_acid) is non-psychoactive. However, some cannabis enthusiasts prefer THC-A over THC because it is believed to have some potential medical benefits, such as anti-inflammatory and neuroprotective properties. All that being said, it’s important to note that when THC-A is heated – such as when it’s smoked, vaped, or dabbed – it converts into THC. As a result, although it is sold as hemp, it is used as cannabis because the user experiences an almost identical feeling, and this product is highly psychoactive. It’s essential to be aware of this fact when using products that contain high levels of THC-A. These products can produce psychoactive effects that are very similar to those of cannabis. Potency and Usage of THC-A DiamondsTHC-A diamonds are some of the most potent hemp-derived cannabis products available, with a THC-A content of 99.9% or higher. This makes them an ideal choice for experienced users who are looking for a high-potency product with strong, fast-acting effects. As a result, unless you are an experienced user, it’s important to use this product responsibly and in moderation, as their potency can be overwhelming. THC-A diamonds can be used in a variety of ways, including dabbing, vaporizing, and even sprinkling onto a joint or bowl of cannabis flower. They’re a versatile product that can be enjoyed alone or mixed with other cannabis products to enhance their potency and effects. Some cannabis enthusiasts also like to use it to make their own cannabis-infused edibles and tinctures. Effects of Dabbing THC-A DiamondsDabbing is a popular method of consuming cannabis concentrates, including THC-A diamonds. To dab, you’ll need a dab rig, a torch, and a dab tool. First, heat up the nail on your dab rig using the torch until it’s hot enough to vaporize the diamonds. Then, use the dab tool to place a small amount of diamonds onto the nail. As soon as the diamonds come into contact with the hot nail, they’ll vaporize, producing a thick, flavorful vapor that you can inhale. Dabbing with THC-A diamonds produces a strong, fast-acting high that can be quite intense for inexperienced users. The effects are typically felt within seconds of inhaling the vapor and can last for several hours. These diamonds are known for producing a euphoric, uplifting high that can leave you feeling happy, relaxed, and creative. They’re also popular among medical cannabis users for their potential pain-relieving and anti-inflammatory effects. Legality of THC-AOne of the most common questions about THC-A diamonds is their legality. Since they are made from hemp-derived cannabis, which is legal under federal law, THC-A is also legal as long as they contain less than 0.3% THC. This means that you can enjoy the benefits of THC-A without having to worry about breaking any laws. Storage and SafetyYou should store this product in an airtight container in a cool, dry place. This will help to preserve their potency and flavor over time. It’s also important to handle the diamonds with care, as they can be fragile and prone to breaking. When dabbing, it’s important to use a dab tool to avoid accidentally damaging the crystals. When it comes to safety, it’s important to purchase THC-A diamonds from a reputable source that uses high-quality plants and safe extraction methods. Deal of the DayWant to try this product? Now is the perfect time for you to do so, as it is offered at unbeatable prices per gram! Whether you’re an experienced dabber or new to cannabis concentrates, THC-A diamonds are a great choice for anyone who wants to experience the ultimate in potency and purity. Just remember to start low and grow slow, as these diamonds are strong! TIP: For the best value, choose the 14g bucket option, where the price per gram is at a minimum. This option provides the most product for your money and is the perfect choice for those who want to stock up on this premium product. Save Big On THC-A Diamonds![]() ConclusionIn conclusion, THC-A diamonds are a highly potent and desirable hemp-derived cannabis concentrate. Whether you prefer to dab, vape, or mix with other cannabis products, the diamonds are a versatile and high-quality product that’s sure to impress. And with our Deal of the Day, there’s never been a better time to try THCA diamonds for yourself! The Cannadelics Sunday EditionStay up-to-date on the latest news and deals from the world of cannabis and psychedelics with our weekly newsletter! With The Cannadelics Sunday Edition, you’ll be the first to know about new products, exclusive discounts and promotions. Don’t miss out on this fantastic resource – sign up for our weekly newsletter below:
The post THC-A Diamonds: The Ultimate High-Potency Hemp-Derived Cannabis Concentrate appeared first on Cannadelics. Via https://cannadelics.com/2023/05/07/thc-a-diamonds-the-ultimate-high-potency-hemp-derived-cannabis-concentrate/ Psychedelics and mental health are big news these days; and LSD is a part of it. Though much was established about the compound last century, new research into LSD today shows its ability to help with major depressive disorder, among other psychological issues. Read on for more information about the Phase II trials recently completed, and what we can expect from this compound in the future. LSD new researchThis new research into LSD comes out of Switzerland, where trials were conducted between University Hospital Basel and University Hospital of Psychiatry. The trials were run by the biopharmaceutical company MindMed. The study is a “Randomised, double-blind, active-placebo-controlled trial using either two moderate to high doses of LSD (100 µg and 100 µg or 100 µg and 200 µg) as intervention and two low doses of LSD (25 µg and 25 µg) as active-placebo control.” The trials used 60 adults above the age of 25 years. All were diagnosed with major depressive disorder (MDD) according to DSM-V standards. The main outcome, according to investigators, was “Change in depressive symptomatology (IDS, BDI), anxiety (STAI), and general psychopathology (SCL-90) compared with active-placebo-assisted psychotherapy.” In order to find this, the study investigators used a few different measurement techniques. They used the Inventory of Depressive Symptomatology, both clinician-rated and self-rated. They also used the Beck Depression Inventory, the State-Trait Anxiety Inventory for looking at change in state and trait anxiety; the Symptom Check List to look at any change in general psychopathology; the Existential Concerns Questionnaire for measuring existential anxiety; the Five Facet Mindfulness Questionnaire to assess changes in mindfulness; and a host of other tests. Nice to see you! Head over to the Cannadelics Weekly Newsletter for regular updates; and a host of awesome promotions on cannabis buds, vapes and smoking devices, edibles, cannabinoids, amanita mushroom products, and a massive variety more. We promote feeling good. Come do it! Some of the other things looked into by the other questionnaires included judging levels of humility, “absorption”, altered states of consciousness, mystical experiences, new physical conditions, perception of therapeutic alliance, mood, personality, religious beliefs, and ongoing effects of treatment. Investigators also took note of physiological responses via different tests. These tests covered things like the changes in brain-derived neurotrophic factor, changes to hypothalamic-pituitary-adrenal function, immunoregulation and Inflammation changes, brain activation related to fearful face processing and working memory processing, brain perfusion during treatment, and changes in sleep patterns. Details of the trialsWe know this is a study where participants were given LSD as a treatment. But what exactly does this mean? And what about all the terms mentioned above? As a ‘double blind’ study, neither participants nor investigators knew which group each participant was in, control or experimental. The experimental group was the group given the higher dose to assess effects, whereas the control group in this scenario, was simply given a lower dose of the same thing. ‘Randomized’ means that the participants were randomly assigned to their groups, with no reason for entrance into one over another. ‘Active-placebo-controlled’ means that a control group was used that got something similar to the experimental group, but not the same exact treatment amount. ‘Phase II’ means the trials were meant to further elucidate how effective the medicine is, and how safe; with initial trials already completed. In terms of how it was done, the experimental group was given 100 μg of lysergide the first time around, and 200 μg the second. These two doses were given about four weeks apart. The control group participants received 25 μg the first treatment day, and the same on the second, spaced the same way as the experimental group. Investigators wanted to know the outcome at week six; this means six weeks after the first dose, and two weeks after the second. The primary outcome measured was change in MDD, which was assessed via the Inventory of Depressive Symptomatology. Investigators also looked at secondary outcomes, which were measured according to self-rated improvements on different scales like Inventory of Depressive Symptomatology, Beck Depression Index, and State-trait anxiety inventory. ![]() After the first dose, patients were followed-up with for 16 weeks. This is important to understand. Trials end, which means the data collection for them ends as well, unless a later follow-up date is set to analyze results past that point. When results therefore say that effects lasted up to 16 weeks after administration, its not saying that the results faded at that time, so much as they weren’t accounted for past that time. MindMed explanation of trialsOn April 23rd, MindMed released topline data on this research, as per BusinessWire, which related that this data “demonstrated significant, rapid, durable and beneficial effects of lysergide and its potential to mitigate symptoms of MDD.” The write-up went on to explain that the high dose regimen led to statistically and clinically significant results on the Inventory of Depressive Symptomatology at the six week mark as compared to the control group. This change was seen up to 16 weeks after the first dose was given, but was not checked after that point. It should be noted that MindMed’s investigational drug was tolerated well. Not only do these trials aim to see if a medication is able to accomplish something, but whether it can do so while not causing a bunch of negative effects. Investigators did track “adverse events, changes in vital signs, and laboratory values” to make that assessment. Said Chief Executive Officer and Director of MindMed, Robert Barrow, “We continue to be encouraged by the positive results being generated on the clinical activity of lysergide by our collaborators at UHB. The statistically and clinically significant improvements observed in this study reinforce preliminary findings that have shown the clinical potential of lysergide in anxiety, depression and other brain health disorders.” Study collaborator Prof. Matthias Liechti added this about how the study came about, “Historical studies of lysergide in MDD demonstrated rapid, robust and sustained improvement in depressive symptoms… We believed it was necessary to confirm the historical studies with ones using modern methods. Hence, we designed this randomized-controlled trial to assess the benefits of lysergide treatment in MDD.” He continued, “Importantly, an active small dose of lysergide was used as the control. We are extremely encouraged by the results we presented today, which demonstrate the strong, rapid and enduring improvements of this compound in patients suffering from MDD. We look forward to publishing the completed results in a peer-reviewed journal along with additional analyses. Our lab will continue investigating the therapeutic potential of lysergide and other psychedelics.” ![]() What else do we know about LSD?Though today’s modern world of medicine might make you believe we simply didn’t know about the beneficial effects of LSD, this is not true at all. In recent years, studying it picked back up, but this really started back in the 1900’s. Originally the compound was synthesized by Albert Hoffman in Switzerland in 1938. It wasn’t until the 1950’s, however, that it became big in the world of US psychotherapy. One of the best known treatment providers and researchers for LSD, was Dr. Humphry Osmond. He concentrated on using LSD for treating both alcoholism and mental disorders. The research on the former provides some of the best information out there on alcohol cessation, even if its not mentioned much today. Osmond, like many others, tested the drug out on himself before administering it to patients. He was the one that coined the term ‘psychedelic.’ His most important work was in conjunction with Abram Hoffer, and called the Saskatchewan trials. These took place at Weyburn Mental Hospital in Saskatchewan, Canada. In total, over 2,000 patients with alcoholism were treated by the end of the 1960’s; with an overall (and pretty amazing) statistic that approximately 40-45% did not drink again within a year of treatment. Matthias Liechti made an interesting point when he brought up wanting to create new research into LSD to test the same things tested back-in-the-day. The real story is that while a lot of information exists, the medical world tends to erase or ignore it; and treats the topic like it didn’t become a thing until the past few years. ConclusionWe see legalizations for mushrooms, and other entheogenic plants, happening in different places. We even see a preemptive legalization of MDMA. Owing to this new research into LSD, and its known-about uses for treating alcoholism and other mental disorders; its very likely that LSD medications will be the next big topic of mental-health conversations. Welcome everyone. We’re happy to see you at Cannadelics.com; where we work hard to bring you the best in independent reporting for the cannabis and hallucinogen spaces. Join us daily to stay in-the-know on important topics, and sign up to the Cannadelics Weekly Newsletter, so you’re always up on what’s going down. The post LSD Will Turn That Frown Upside Down, According to New Research appeared first on Cannadelics. Via https://cannadelics.com/2023/05/06/lsd-will-turn-that-frown-upside-down-according-to-new-research/ Advertising on social media is synonymous with running any kind of business; yet the weed industry gets shut out by harsh advertising restrictions. A recent announcement by Twitter about its new cannabis advertising policy looks to change this, and pave the way for marijuana brands to show their stuff on social media. Twitter first loosened cannabis advertising policy in FebruaryDrugs like cannabis and social media have gone together like oil and water thus far; mainly because of harsh cannabis advertising policies shared by the biggest social media platforms. This applies to Facebook, Instagram, Twitter, and TikTok, as well as Google in general. In recent months, Twitter has broken away from this status quo to create a new cannabis advertising policy. The shift started this February, when the social media giant first changed policy to let in advertising to the US markets by some cannabis companies. This was not a free-for-all, and applied only to legal and ‘approved’ cannabis companies, as well as other advertisers. Twitter stated at the time, “We permit approved Cannabis advertisers to target the United States.” Unsurprisingly, with this as the first beacon for hope in social media, many cannabis companies quickly jumped onboard; though some were more skeptical and wanted to see what would happen. In the former group, vape brand Pax was quick to get in on it, with vice president of marketing, Luke Droulez, explaining that the company is “among the first of Twitter’s cannabis advertising partners.” Welcome readers! Please check out the Cannadelics Weekly Newsletter for direct email updates; and a ton of offers for cool swag like weed flowers, vapes & smoking paraphernalia, edibles, cannabinoids (like HHC), amanita mushroom extracts, and way more stuff. Let’s all feel good together! This was not across the board, as exemplified by Theory Wellness, a multi-state cannabis company from the East coast. CMO Thomas Winstanley believed this new approach to be “more symbolic than it is practical for our operations.” He pointed out that Twitter already opened this advertising market in Canada, for which it holds different restrictions. Twitter quickly upgraded cannabis advertising policy furtherThat was back in February. Now it’s less than three months later, and Twitter is already expanding out this policy further. In an ad posted recently, the company stated it had “gathered meaningful feedback from the cannabis industry which we have taken into consideration to create even more opportunity.” The post was put up by Alexa Alianiello, Twitter head of sales and partnerships. The ad continued, “We have also made some changes for medical licensees and opened up additional recreational markets (some restrictions apply).” Current rules are publicly posted in the company’s ‘Drug and drug paraphernalia’ policy. According to Rosie Mattio, CEO of Mattio Communications, a cannabis industry marketing company, the following states now can have medical products marketed to them: Alabama, Arkansas, Florida, Minnesota, Mississippi, Missouri, Oklahoma, Pennsylvania, Puerto Rico, Rhode Island, South Dakota and West Virginia. Ads for Missouri’s adult use market also get a pass. As per MJBizDaily, Mattio explained that these policy updates are meant to widen the market and provide “a lot more opportunity for these brands to reach consumers and teach them about the actual product, (as opposed to) it just being a brand-awareness type of play.” Twitter wants to include as many markets as possible it seems. The platform also allows marijuana ads for Canadian and Thai consumers. As of right now, Twitter is going at it alone. Facebook, Instagram, TikTok, and Google are all held off by their parent companies, or internal policies, which don’t allow drug advertising. Google is a minor exception in that it does permit some advertising for specific hemp and CBD products. ![]() Twitter woesWith this news, Twitter gives new hope to the cannabis industry. And considering the problems it has, particularly related to decreased sales by legal companies, this is a very positive move. It’s been a rough ride as of late, and this news means a new avenue for companies to find customers. It also means Twitter makes itself the social media focus of the industry, which could help it out as well. After all, Twitter has its issues too. As per Alianiello’s post, “Earlier this year we took measures to relax our Cannabis Ads policy in certain US states, allowing advertisers to promote cannabis-related content for CBD, THC, and cannabis-related products and services. This was the largest step forward by any social media platform to create more opportunities for responsible cannabis marketing.” This is true. But why would Twitter want to go out on this limb? Could it be a way to try to fix its own problems? While Twitter has soldiered on over the past decade, it hasn’t done so easily. According to the Wall Street Journal via Ars Technica, from 2012 to 2021, the company posted net losses in eight of the 10 years. In 2022, it had not shown an annual profit since 2019. Twitter is no longer a public company as of October, 2022, when the company was bought in full by Elon Musk. This happened in October, for $44 billion. Musk took Twitter off the NYSE, and made it a privately held company. According to Ars Technica, “Many big companies cut advertising spending on Twitter shortly after Musk’s acquisition, largely over concerns about content moderation. Twitter offered special deals to advertisers throughout December 2022, but it wasn’t enough to prevent the 40 percent revenue and earnings declines.” Of course, Musk didn’t jump onto a well-functioning ship if the company was already having issues making a profit. Musk lamented in a February Twitter post that he had had a hard three months since he had to save Twitter from bankruptcy. At the time he took it over, he said the company was losing $4 million daily. He immediately got to work, cutting staff to lower expenses, getting rid of thousands of contractors, and essentially telling anyone who stayed that they’d be subject to long and intense work days; something he seemed to want a direct commitment for. And something which implies quite an extra workload if it had to be said. Many resigned at that time, taking three months severance instead. ![]() Twitter and cannabis – a symbiotic relationship?Twitter came into being in 2006 as a way to post short ‘tweets’ (originally only 140 characters) in real-time. The character limit was raised in 2017 to allow 280 characters. The site initially gained prominence in 2007 via the SXSW festival, in which posters could see their posts come up in real time. Twitter grew to a user base of 30 million active users a month. But seemed to have issues introducing new products like Vine and Periscope, both of which failed. In fact, Twitter hasn’t gotten anything else to work outside of its platform. This could be at least in part due to bad management. Twitter has had several changes in leadership over the years; something that happens more frequently when companies are in turmoil. As of right now, according to Business of Apps, Twitter has 368 million active daily users, and a US user base of 63 million. Though Twitter did generate about $4.4 billion revenue in 2022, this was an 11% year-on-year decline. Of the revenue it did make, a huge 90% came from advertising. And that’s important here, as the most recent move the platform made, was to introduce, and then widen, advertising for cannabis products. This change in thought is likely related to Elon Musk taking over. Many advertisers left at the time, possibly related to statements made by Musk about unblocking accounts meant to be blocked forever; something he did do, at least to a degree. Many advertisers didn’t like the idea of their ad content being on or near what they considered undesirable content. The recent news of Twitter instituting an advertising policy for cannabis, seems in line with the idea of increasing advertising in general; Twitter’s main source of revenue. And in so doing, it does create a symbiotic relationship between the social media platform, and the legal weed industry. Musk now allows advertising for what is more and more becoming a failing industry; and Musk gets to increase advertising revenue, for his possibly failing social media platform. ConclusionA possible positive to all this, is that it could help small businesses. Twitter’s move to open advertising on social media, might provide a way for smaller companies to get a louder voice in an industry that practically runs them over. Either way, and regardless of turnout, this new policy represents a new shift in how cannabis is advertised. Welcome to the site. We appreciate you dropping by Cannadelics.com; a news source designed to bring you top-level independent reporting for the cannabis and hallucinogen landscapes. Join us daily to remain in-the-loop, and subscribe to the Cannadelics Weekly Newsletter, so you’re up-to-date on all the news. The post New Twitter Cannabis Advertising Policy Creates Symbiotic Relationship appeared first on Cannadelics. Via https://cannadelics.com/2023/05/06/new-twitter-cannabis-advertising-policy-creates-symbiotic-relationship/ Colorado is getting it done, and getting it done fast. A bill just passed through both sides of the Colorado Congress, with regulation measures in accordance with the voted-in psychedelics legalization last fall. Now awaiting sign-off by the governor, this bill is the first one to get the new industry rolling. Read on for details. Bill passageIt often takes a bill a lot of time to pass congress, whether in a state legislature, or federal. In the case of Colorado’s SB23-290, this bill is moving at record speed. As the legislative session ends on May 6th, the goal was to get it passed before that deadline. Entitled the Natural Medicine Regulation And Legalization bill, it passed both sides of Congress last month. Since the House made amendments, these amendments had to be approved by the Senate. It approved them on Tuesday May 2nd, in a vote of 32-3. Then the Senate went on to vote a final time on the final write-up, and approved it 24-11. The only thing left is for Governor Jared Polis to sign it into law. The bill was only introduced a few weeks ago (April 18th), by Senate President Steve Fenberg. Meaning it went through all of Congress in far less than one month. When the voter ballot passed last year to legalize use of psychedelics, it included a measure to create an advisory board to give recommendations for regulatory laws. Though this might still happen, this bill was offered with no such advisory board in existence. Cool that you’re here! We’ve got the Cannadelics Weekly Newsletter to provide direct updates; and which comes chock full of promotions for cannabis buds, smoking devices and vapes, edibles, cannabinoids (including delta-8), amanita mushroom extracts, and a wide selection more. Let’s all get stoned responsibly! The bill filed by Fenberg contains some provisions that are different from the voted-in measure. The advisory board was meant to help create legislation with a greater lean toward holistic healing. As of right now, anything established, was established without that input. What to expect for Colorado psychedelics regulationThere’s not much reason to expect the governor won’t sign off (though its not impossible). Assuming he follows through on his end, and the bill stands, we now have information on how Colorado will govern its psychedelics industry, and with what kind of regulation attached. Here are some of the key points, some of which do wander from the original ideas of the vote: Personal Use and cultivation
Natural Medicine facilities
Licensing and regulatory agencies
![]()
Concerns and workaroundsSome concerns are standard, or at least, standard talking points. While medications like opioids kill tens of thousands yearly and are prescribed easily by doctors; there are fears attached to possible damage caused by this legalization. Even without psychedelics providing any real death or permanent injury count, the bill stipulates: “although there may be tremendous potential in utilizing natural medicine for managing various mental health conditions, healing, and spiritual growth, this potential must be appropriately balanced with the health and safety risks that it could pose to consumers as well as the cultural harms it could pose to indigenous and traditional communities that have connections to natural medicine.” In terms of cultural harms, the bill sets up the aforementioned advisory committee. According to the bill, this is because “Considerable harm may occur to indigenous people, communities, cultures, and religions if natural medicine is overly commodified, commercialized, and exploited in a manner that results in the erasure of important cultural and religious context.” Where the original bill fell short in lawmaker’s minds, the House added a bunch of amendments to try to account for different issues. These include provisions for record sealing (mentioned above); that psychedelic use won’t violate either probation or parole; that cultivation is allowed in a place other than the cultivator’s own residence, so long as its for personal use, in a private residence, and in an enclosed space; that officials should keep track of drug use trends; and that regulators must both make clear what a federally recognized tribe is, and institute an equity plan. The last point is common in cannabis legalization measures, but has not shown to be a useful tool. Unfortunately, while its good for government optics, such equity programs undermine the cost of operations. In expensive systems of regulation, where operating costs and taxes are high, the groups which would benefit most by such equity plans, tend to be the ones without the means to use them at all. Perhaps this instance will provide a different outcome. ![]() How Colorado got hereHow did we end up talking about how Colorado will institute regulation for a psychedelics market? It’s not like every state is doing it. In fact, Colorado is the second state to pass a measure to legalize some amount of psychedelic use. The first was Oregon, which passed measure 109 via voter ballot during the November, 2020 elections. Two years later, and Colorado did the same thing. It put Proposition 122 in front of the public, called the Decriminalization, Regulated Distribution, and Therapy Program for Certain Hallucinogenic Plants and Fungi Initiative. 53.64% of the population voted yes to the measure, which totaled 1,296,992 votes. 46.36% were not up for this change, which accounted for 1,121,124 votes. Though the bill defined certain plants as natural medicines from the get-go, it came with few specifics, much like Oregon’s original voted-in bill. However, from the beginning, Colorado’s vision was a bit different from Oregon’s; and the state incorporated different ideas from Oregon on certain points. Like in not letting individual locations opt out of the legislation, allowing for more than just psilocybin, and allowing use outside of healing centers. Colorado had a big year for drug legalizations in 2022, and separately went a step further. At virtually the same break-neck speed, the state introduced and passed a bill to preemptively legalize medical MDMA. This legalization is specifically contingent on the US federal government legalizing MDMA for medical use first. So though the bill passed, it won’t be useful until a federal law passes. Even so, Colorado marks the first state to make such a legalization for MDMA. ConclusionWith not much standing in the way, and a desire to meet a deadline; it seems unlikely that Governor Polis won’t sign the new Colorado psychedelics regulation bill into law. Within a few days we should know the answer for sure. Welcome all. We appreciate you dropping by Cannadelics.com; a news platform focused on independent reporting of the cannabis and hallucinogen landscapes. Visit us whenever possible to keep up with the Joneses; and check out the Cannadelics Weekly Newsletter, to get updated on everything important. The post Colorado Passed Psychedelics Regulation Bill appeared first on Cannadelics. Via https://cannadelics.com/2023/05/05/colorado-passed-psychedelics-regulation-bill/ When I grew my last flush of mushrooms, I noticed something interesting in the soil – what appeared to be small, flat, golden flakes. “Is there gold in soil??” I thought to myself. So naturally, I began doing some research. As it turns out, it’s more likely that what I found was mica or vermiculite, but either way, it led me to dig deeper into whether a connection between gold and fungi exists at all… and as it turns out, it does!Do mushrooms store gold? Can they be used to located gold deposits in the earth? Are there any benefits to consuming gold? Let’s take a closer look. Golden mushrooms – a biological advantageAlthough research is minimal, the most recent discovery on this front was a fungus coated in particles of gold. The fungus in question is called Fusarium oxysporum, grows throughout western Australia, and it absorbs, dissolves and redeposits gold particles from its surroundings, while some of the gold attaches to the strands. According to researchers, “The process is highly unusual as gold is a chemically inactive substance; the fact that gold responds to the fungus in this way is quite surprising.” ![]() It has yet to be determined how exactly the mushrooms find and identify gold, but it does to seem provide a biological edge over non-gold storing fungi, although the reasons why or mechanisms of how are also a mystery. However, the study noted that these gold-coated mushrooms grow larger, spread faster, and play host to a much more varied range of other fungi – meaning they add more biodiversity to the soil than their counterparts. “Many types of fungi degrade and recycle organic matter, and some are known for their interactions with certain metals, including aluminum, iron, manganese and calcium,” said Tsing Bohu, lead author from the study and researcher with Australia’s Commonwealth Scientific and Industrial Research Organization (CSIRO). “But gold is so chemically inactive that this interaction is both unusual and surprising — it had to be seen to be believed,” Bohu added. The findings, which they plan to expand on in the future, were published on May 23, 2019, in the journal Nature Communications. Benefits of consuming gold for humansEdible gold has been consumed for thousands of years, and still is to this day. The earliest evidence of gold consumption is found in ancient Egypt and dates back almost 5,000 years. Egyptians believed gold could be used to connect to the divine, so it was used regularly for spiritual, physical, and emotional purification. The added gold to many different elixirs that they would use medicinally to restore and rejuvenate cells in the body. It’s also believed that Cleopatra used some form of gold beauty treatment daily, including baths infused with gold and a face mask made of pure gold. Since then, it has been used with relative consistency throughout many different regions, particularly Japan, China, and India where it was often prescribed by physicians for numerous different ailments. Edible gold was also very popular among the courts of the kings of European countries in the Middle Ages. Doctors during those times prescribed gold to help with arthritis, pain, and various types of inflammation. Edible gold is still considered a delicacy in many parts of the world and is often used as a garnish for baked goods and alcoholic beverages. In Europe, the Food Safety Administration (EFSA) has approved gold (E-175) as a food additive. Gold is safe to eat because it is a non-reactive element that is not absorbed during digestion. The purity of edible gold should be around 24 karats, above what is used in standard jewelry. Gold mixed with other metals can be toxic if consumed. Gold-storing plants and animalsIn Australia, it seems the harboring of gold isn’t limited to mushrooms alone. Geologists from CSIRO have made some fascinating discoveries when it comes to finding gold deposits in nature. For example, they found termites storing gold in their mouths for extended periods of time, as well various types of trees in the Kalgoorlie region that pull gold out of the earth and deposit it in their leaves. Thank you for stopping in. Head over to the Cannadelics Weekly Newsletter for direct updates; and get access to awesome deals on cannabis buds, vapes, edibles, smoking devices and equipment, cannabinoid compounds, and some psychedelic products! Go get high responsibly! And despite the lack of research, this is something that has been known about for quite some time. The U.S. government even published a report that describes exactly how much gold can be found in various species of animals and plants, including humans. The report, titled “Gold Content of Water, Plants, and Animals,” was written by Robert S. Jones and published by the Department of Interior in 1970. You can view the full report here. Here are a few notes from the report:
To quote the report: “Excluding the earlier work of Noddack and Noddack (1939), marine animals contain, by far, the least amount of gold and terrestrial animals contain the most gold. Bones, teeth, and phosphorite are calcium phosphates with comparable gold contents. These naturally occurring compounds appear to be similar in their gold content, irrespective of their origin, and probably reflect the gold level of their environment. The known content of gold in animals apparently supports Vinogradov’s (1953) observation that the amount of gold found in animal organs is entirely casual and that there are no auriferous animals anywhere in the world.” Can fungi be used to locate gold deposits?![]() There is ongoing research as to whether mushrooms are somehow linked to gold deposits within the earth. Because traditional methods of mining for gold aren’t exactly eco-friendly, if there is a connection between fungi above ground and gold beneath the surface, that could have a huge impact on the gold recovery process and the gold industry as a whole. Locating gold deposits through fungi, trees, and insect nests is more cost efficient and less harmful to the environment than drilling is. It’s also believed that this method of prospecting for gold could be more accurate than what is already available, which would decrease costs and carbon footprints even further. Final thoughtsWelcome readers! Thanks for hanging out with us at Cannadelics.com; an independent publication that brings you new and ongoing stories in the cannabis and hallucinogen spaces. Come ’round regularly so you don’t miss out on anything; and subscribe to our Cannadelics Weekly Newsletter, to ensure you’re never late to get the news. The post The Connection Between Mushrooms and Gold appeared first on Cannadelics. Via https://cannadelics.com/2023/05/04/the-connection-between-mushrooms-and-gold/ E-cig maker Juul has really been a target in the last few years, with tons of lawsuits and government actions sent its way. In the newest story, Juul signed a settlement for a case that sees it paying out hundreds of millions to six different states (plus DC). How much sense does this make? Or is Juul just a scapegoat? The Juul settlementThis most recent settlement Juul underwent, involves the states of New York, California, Massachusetts, New Mexico, Illinois and Colorado, plus Washington DC. Altogether, these locations will be paid $462 million. New York is set to receive $112.7 of this, but over an eight year period, and the money must be used for programs to keep kids from using e-cigs. California will get $175.8 million, specifically for e-cig research purposes, education, and legal enforcement. The Massachusetts share is $41.7 million, and part of that goes to pay for vape addiction services. Colorado gets close to $32 million, New Mexico is to be paid out $17 million, and Washington D.C. receives approximately $15 million. While not stated in the reference article, its expected that Illinois would get the remaining $67.8 million. The announcement came on Wednesday April 12th by five different attorney generals for the states in question. While Juul has had to deal with many lawsuits, this case marks the largest multi-state settlement the company has thus far entered into. All told, Juul has settlements with 45 states, for a total of about $1 billion. Cool that you’re here. We’ve got the Cannadelics Weekly Newsletter for you to stay updated; and which comes with a load of offers for cannabis buds, vapes and smoking equipment, edibles, cannabinoid compounds, amanita mushroom products, and a boatload more. It’s good to feel good. Let’s all do it! Beyond payouts to the states (and DC) the lawsuit also works to put limits on how Juul can sell and market its products; part of which involves placing products behind store counters, and verifying the age of buyers. Said New York Attorney General Letitia James, “There is no doubt that Juul played a central role in the vaping epidemic today. Juul is paying for widespread harm caused and will undergo severe restrictions on its marketing and sales practices.” Juul’s response through a spokesperson was that the company is now closer to “total resolution of the company’s historical legal challenges and securing certainty for our future.” And that “Now we are positioned to dedicate even greater focus on our path forward to maximize the value and impact of our product technology and scientific foundation.” According to its spokesperson, the company’s main priority is to obtain an authorization through the FDA to be able to legally market its products in the US. The authorization is through the Premarket Tobacco Product Applications, for which the FDA already turned the company down last June. A month later, that decision as put on hold, and subsequently dropped, making it potentially possible in the future. Did Juul products cause a lot of deaths and injury?You’d think from this settlement that Juul must have really caused some damage. I mean, there’s got to be a body count, right? That’s the thing, there isn’t. In fact, there’s not one death attributable to the company, and far as I can find, not one direct story of injury either. Isn’t this reminiscent of harsh cannabis laws that paint the plant as the worst, most-dangerous thing ever…even without death and injury attached? The suits aren’t actually over death and injury, because there isn’t one confirmed case of either. Not one. In fact, all cases are over marketing the cigarette alternatives to minors. Nicotine products are illegal to market to children, so this includes Juul’s non-cigarette vapes. Legally this makes sense, as Juul must follow the same laws as tobacco companies under current regulation. Maybe it doesn’t make rational sense in terms of the ability of death and injury between the two (cigarettes vs vapes), but its fair play to expect the company to follow the laws in place, right? Well, here’s another thing, Juul has apparently not advertised to kids in any way since 2019. Plus, the company also related that since that time, (when it also discontinued some flavors), use of Juul products by underagers dropped by 95%. Despite the fact there aren’t official injury reports for any minor or adult related to the products, and an effort by the company to be in line with regulation, James made the statement that Juul is: “Taking a page out of big tobacco’s playbook” and that “Juul misled consumers about the health risks of their products.” She points out that the settlement will require Juul not use anyone less than 35 years of age in advertising if the ad can be seen by underagers. Let’s get realistic – why literally none of this makes senseThus far, Letitia James is doing great at exemplifying grave misunderstandings about this topic. Something made clear when she said that Juul misled people to believe that the e-cig products are safer than cigarettes; pointing out that some vape pods have as much nicotine as a pack of cigarettes. The problem with this statement? They are less dangerous. Like, by leaps and bounds. ![]() You see, 480,000 people in the US die a year from cigarette smoking, whereas Juul is not associated with a death count or injury count at all. Just the fact that vaping doesn’t involve lighting something on fire and breathing it in, means its automatically safer, so long as bad additives aren’t used. How many actual vape injury deaths? As of February 2020, from the inception of vaping until that point, not more than 68 deaths. Pretty much all related to added chemicals, which are not directly related to the act of vaping; and can be regulated out. And that’s the whole argument against vaping that exists…that bad chemicals can be used. In fact, when the CDC talks about ‘vape injury’, that’s what its talking about, the injury that comes out of bad additives, like vitamin E acetate. Yet, these are almost always associated with black market products, and can be simply eliminated through regulation. They have 0% to do with vaping nicotine over smoking it, or vaping nicotine at all. So, no actual safety issues are technically associated with the company. What is directly associated with the company, is helping people stop smoking. Smoking is the thing that can not only kill people, but which also takes out approximately 41,000 people a year through secondhand smoke. Funny, haven’t heard many complaints about secondhand vape damage… Let’s make it even more ridiculous. Juul can’t use anyone under 35 in advertising, nor market anything that might be seen by an underager. Does that apply to alcohol too? It must, right? I mean, alcohol is also illegal for underage kids, and is also attached to a massive death and injury toll. Just like smoking, it hurts those that don’t partake, through actions like drunk driving. Yet…there are commercials on TV for alcohol, and billboards everywhere, and pages in magazines full of ads. That’s because alcohol ads don’t have to be approved for either print or broadcast. What do the five attorney generals think of that? And for that matter, what about the UK now promoting vaping over smoking? To the point of a plan to hand out vape materials to smokers in order to get them to stop. Is this because vaping is just as dangerous as smoking? What do the attorney generals say in regards to that policy? Let’s let some logic in#1, and I really can’t stress this enough; does it matter if kids are marketed to if the product in question (vapes) can keep them from using the actually deadly product (cigarettes)? Shouldn’t we desire this? It’s not like they’re not going to know what smoking is; its in every big TV show and movie. It’s in the houses they go home to, or the ones they visit. Its on every street corner. Is the government’s logic that kids should only know about smoking? Sounds like it. #2, there are real problems to worry about, like opioids and alcohol, and actual smoking. According to a National Survey on Drug Use and Health for 2017, in just the age range 12-17, 770,000 kids misused opioids that year. Those are the drugs that killed close to 100,000 people in 2021. Want to guess what that number would be today, six years later, as the problem has only grown? And what about the National Institute of Health (NIH) report that states in 2019, in the same 12-17 age group, 414,000 kids were diagnosed with alcohol use disorder. You know, the substance that kills 140,000 people a year? Including over 10,000 road deaths attributed to it in 2016 according to the CDC? And let’s not forget actual smoking. According to the CDC again, in 2019, about one quarter of middle school kids and a half of high school kids said they tried tobacco products; do we really prefer this entire number use cigarettes over vaping?? ![]() #3, and possibly most important for this specific story, there really aren’t death or injury statistics attached to Juul. That should matter. All this talk of vape injury isn’t related to the company specifically, so why should it constantly be associated? Literally, not one headline that directly implicates this specific company in any of the stories of vape injury. It’s literally not a part of it, but taking the fall entirely. Why? That’s like if there’s a story of tainted milk by some small company, and then every milk producer is called out for having dirty products. Juul is gone at like it murdered children, but the reality is that not one thing has been pinned against it. Go ahead and check the internet. The most you’ll find in a search for ‘Juul deaths’ is vague talk of lung injury, with nothing directly associated to the company. It’s just similar products in that they’re vaped. Are all pills the same even if they look similar? Can a Tylenol pill and an Oxycontin get confused? Should we not take any pills because of this possibility? #4, one last point. Like it or not, the FDA has continually stopped progress in getting people to stop smoking, while constantly promoting measures that will likely only promote cigarette use. For example, last year nicotine gummies were almost a thing, but then the government wiped it out before it could start. Imagine that, a product that could get rid of the damage of smoking, yet the FDA decided it was roundly better to have people smoke. And on the other end? Biden introduced an idea to reduce nicotine in cigarettes, something that has shown people to smoke more, despite a handpicked study from 2015 that attempts to say otherwise. And maybe that makes sense as cigarettes have become a government industry nearly everywhere. What do I mean? The government makes so much in tax money off the products, it eclipses the earnings of the manufacturers, making the government the main beneficiary of tobacco sales. Perhaps its simply not economically good for the US to do anything that will actually bring down smoking numbers. ConclusionIs this latest Juul settlement just another indication the company is being used as a scapegoat by the US, while it continues to push cigarette sales, and bar anything that can get in the way? You be the judge. But you might want to start that judgement by doing the search on death and injury associated. And then maybe do the same for cigarettes. Hello everyone. Thanks for making it to Cannadelics.com; a news site in the independent realm, here to bring you the best in cannabis and hallucinogen reporting for today’s industry. Head out way frequently to stay aware of everything happening, and subscribe to the Cannadelics Weekly Newsletter, to ensure you’re never late to get a story. The post Is Juul a Scapegoat? Company Set to Pay Millions in Settlement appeared first on Cannadelics. Via https://cannadelics.com/2023/05/02/is-juul-a-scapegoat-company-set-to-pay-millions-in-settlement/ Looking for a new and exciting cannabis product to try? Cannadelics’ Deal of the Day offers a 15% discount on THC-P flower, a potent and unique hemp-derived psychoactive product. Made from premium hemp flowers infused with a 99% THC-P distillate, THC-P hemp flower comes in four tasty strains with unique effects and flavor profiles. In this article, we’ll explore the benefits, effects, legality, storage, and other important information about this flower. We’ll also take a look at hemp flowers in general and provide some insight into other psychoactive hemp products available on the market. THC-P flower is a sticky nug covered in THC-P oil that burns slowly and offers a complex and tasty profile. It is a legal category of hemp products that offers users a powerful psychoactive experience. While there are no long-term, definitive studies on the effects of THCP, many users report a range of benefits and effects, including a heavy buzz, mental and physical experiences, an intense experience, and relaxation. If you’re looking for a new and exciting cannabis product to try, THC-P flower is a great option. Tip: Get an additional 15% discount with Delta15 coupon code. Don’t miss out on the opportunity to try it at a discounted price with Cannadelics’ Deal of the Day. ![]() (With Delta15 coupon code) Exploring THC-P Flower: Benefits, Effects, and MoreCannabis enthusiasts are always on the lookout for new and exciting products that can offer a unique and powerful experience. One such product that has recently gained popularity is THC-P flower, a hemp-derived cannabis product that is known for its potent effects and unique profile. What is THC-P?THC-P, or THCP, stands for Delta-9-tetrahydrocannabiphorol, a type of THC that is significantly more potent than other Delta-9 THC. THC-P is hemp-derived, made in the USA, and 100% natural. It is a legal category of cannabis products that offers users a powerful psychoactive experience. THC-P Flower: Strains and PotencyTHC-P flower is a sticky nug covered in THCP oil that burns slowly and offers a complex and tasty profile. It comes in four strains: Apple Fritter (hybrid): The Apple Fritter strain is a popular choice for those who are looking for a balanced high. It offers a mix of cerebral and physical effects and has a sweet and spicy flavor profile. The Apple Fritter strain is also known for its relaxing and calming effects, making it a great choice for those who want to unwind after a long day. Green Goblin (sativa): The Green Goblin strain is a sativa-dominant strain that is known for its energizing and uplifting effects. It has a sweet and earthy flavor profile and is a popular choice for those who are looking for a daytime high. The Green Goblin strain is also known for its ability to boost creativity and focus, making it a great choice for those who need a little extra motivation to tackle their to-do list. ![]() Grape Zkittlez (indica): The Grape Zkittlez strain is an indica-dominant strain that is known for its relaxing and calming effects. It has a fruity and grape-like flavor profile and is a popular choice for those who want to unwind and de-stress. The Grape Zkittlez strain is also known for its ability to induce a deep sense of relaxation, making it a great choice for those who struggle with insomnia or other sleep disorders. Monster Cookies (indica): The Monster Cookies strain is an indica-dominant strain that is known for its calming and sedative effects. It has a sweet and nutty flavor profile and is a popular choice for those who want to relax and unwind. The Monster Cookies strain is also known for its ability to relieve pain and inflammation, making it a great choice for those who suffer from chronic pain or other inflammatory conditions. THC-P flower is a high-potency product, as it is made from a 99% THC-P distillate, with each gram of the flower containing 36.2mg of THC-P. This makes it one of the most potent cannabis products available. Benefits and EffectsWhile there are no long-term, definitive studies on the effects of THC-P flower, many users report a range of benefits and effects. These can include:
The potency and unique effects of this flower make it a popular choice for those who are looking for a powerful psychoactive experience. It is also a versatile product that can be consumed in various ways, including smoking, vaping, and making edibles or tinctures. Legal StatusAs a hemp-derived product, THC-P is legal in the United States as long as it contains less than 0.3% Delta-9 THC. This means that you can purchase and consume it without worrying about legal repercussions. However, it is important to note that the legal status of psychoactive cannabinoids may change as regulations surrounding cannabis products continue to evolve. Hemp Flowers: An OverviewHemp flowers, also known as CBD flowers, are the flowers of the hemp plant that contain high levels of CBD and other cannabinoids. Unlike marijuana, hemp contains less than 0.3% Delta-9 THC, making it a non-psychoactive product. Hemp flowers are a popular choice for those who want to experience the therapeutic benefits of cannabis without the psychoactive effects. Hemp flowers come in various strains, each with its own unique effects and flavor profile. Some popular strains of hemp flower include:
Hemp flowers can be consumed in various ways, including smoking, vaping, and making edibles or tinctures. They can also become psychoactive by infusing them with distillates, as is the case with THC-P flower. One interesting exception is the top-selling THCA flower, which is popular thanks to a legal loophole that allows you to buy psychoactive flowers online. This is because while THCA is not psychoactive by itself, it converts into Delta-9 THC when heated (such as when smoked or vaped), so for all matters, smoking THCA flower feels the same as smoking cannabis. Other Psychoactive Hemp FlowersWhile THC-P flower is a unique and potent product, there are many other psychoactive hemp flowers available on the market. Some of the most popular options include Delta-8 THC flower, THCA flower, THC-O flower, and HHC flower. Each of these products offers its own unique effects and benefits, so it is essential to do your research before making a purchase. Safety and StorageWhen consuming THC-P flower, it is important to start with a low dose and gradually increase it to avoid overconsumption. It is also important to be aware of the potential side effects, which can include dry mouth, red eyes, dizziness, and paranoia. As with any cannabis product, it is essential to use it responsibly and in moderation. When storing your this flower or other hemp flowers, it is important to keep them in an airtight container in a cool, dark place to maintain their potency and freshness. Keep them away from children and pets and never operate heavy machinery while under the influence of cannabis products. THC-P Flower: Takeaway Points
ConclusionTHC-P flower is a unique and potent hemp-derived cannabis product that offers users a powerful psychoactive experience. Made from hemp flower infused with 99% THC-P distillate, this sticky nug covered in THC-P oil burns slowly and offers a complex and tasty profile. Each strain is known for its unique effects and flavor profile, making it a versatile and enjoyable product for cannabis enthusiasts. While there are no long-term, definitive studies on the effects of THC-P, many users report a range of benefits and effects, including a heavy buzz, mental and physical experiences, an intense experience, and relaxation. If you are interested in trying the THC-P flower or other hemp flowers, be sure use the Delta15 coupon code for an additional 15% discount. ![]() (With Delta15 coupon code) Interested in staying up-to-date on the latest cannabis news, product releases, and exclusive discounts? Sign up for the Cannadelics Sunday Edition, our weekly newsletter that delivers all the latest cannabis content straight to your inbox. As a subscriber, you’ll be the first to know about new product releases, upcoming events, and exclusive promotions. Plus, you’ll gain access to educational content and insights into the latest cannabis research and trends. To subscribe simply put your email below: For all the latest from Psychedelics and Cannabis, plus some exclusive deals on premium products, subscribe to our weekly newsletterThe post THC-P Flower: A Potent and Unique Hemp-Derived Cannabis Product appeared first on Cannadelics. Via https://cannadelics.com/2023/05/02/thc-p-flower-a-potent-and-unique-hemp-derived-cannabis-product/ It’s a horrible topic that we can’t stop talking about because it doesn’t stop being a horrible topic. One of the biggest issues in the world of health and drugs is the opioid epidemic, and the large and growing number of overdose deaths from these doctor-prescribed medications. Research on different fronts point to the use of weed as a way to lower opioid use, with a recent study related to payments once again backing up that idea. The researchThe opioid issue is huge, and the medical industry is constantly commenting on it, and how to deal with it. In a recent study, investigators showed a monetary connection which indicates that places with legalized weed, also have lower opioid prescription and use rates. However, the study comes with some concerning points. The study, entitled Using Penalized Synthetic Controls on Truncated data: A Case Study on Effect of Marijuana Legalization on Direct Payments to Physicians by Opioid Manufacturers, was put out by researchers from the University of Florida, University of Southern California, and Purdue University. In the study, investigators assess data from drug transactions of direct payments from opioid manufacturers, directly to physicians. In this case, specifically between 2014-2017. The purpose? To identify if these payments are affected by the inclusion of medical cannabis policies. In order to do this, the researchers used a “a novel penalized synthetic control (SC) method that accommodates the zero-payment related latent structures inherent in these payments.” Thank you for coming by. Subscribe to the Cannadelics Weekly Newsletter for email updates; and for sweet offers on tons of swag like cannabis flower, vapes and other smoking-related equipment, edibles, cannabinoids, amanita mushroom extracts, and so much more. We promote feeling good. Come do it! The paper makes this statement, “Physicians are the primary gatekeepers for deciding medication for patients needing pain management.” This is important to remember as death numbers spiral out-of-control. As medical marijuana is employed in more places and for more things, more doctors might be driven to switch up how and what they write for pain. Study findingsThe study results indicate a “a significant decrease in direct payments from opioid manufacturers to pain medicine physicians as an effect of [medical marijuana law] passage.” It found that “physicians in states with an MML are prescribing fewer opioids.” The thought is that this is “due to the availability of medical marijuana as a substitute.” To get more specific, this “substitution effect is comparatively higher for female physicians and in localities with higher white, less affluent, and more working-age populations.” This could indicate that female doctors might be friendlier in general to the idea of medical marijuana, or it could speak to females having less powerful relationships with opioid producers. It’s hard to say which. The study found that in 2015, doctor’s prescribed 49% more opioid treatments than non-opioid treatments in terms of 30 day prescriptions, as well as prescribing 49% more days of prescribed medication for opioid vs non-opioid treatments. In states where no legalization measure was applied, the ratio remained about the same for opioid vs non-opioid prescription, at about 1.38:1. For states that did apply a medical marijuana legalization within the years 2015-2017, the study found that the same ratio decreased from 1.57:1 to 1.52:1. The same decrease in ratio was likewise seen when looking at the number of days of medication prescription when comparing opioid to non-opioid medications, in states that passed a medical legalization. These numbers imply something weird though, which the researchers don’t talk about. They imply that states without medical weed policies, automatically prescribe less opioids. After all, a 1.38:1 ratio is lower than either 1.57:1 or 1.52:1, indicating non-legal states prescribe less before and after a legalization. This, to me, seems suspect, or at the very least, very much in need of some sort of explanation. Nothing of the sort is given. ![]() Realistically, according to this data, researchers could say that states with medical weed policies, have uniformly higher opioid prescribing, and likely higher use. And that seems a big enough point that it deserves expansion, which it didn’t get. In fact, all the researchers say after presenting the information, is “We leave further analysis of the possible effect of MML passage on patient care for future research.” What this means, is impossible for me to say based on what is provided. But it’s an odd thing not to address. Wait a second, how did they put this together?The thing about a lot of research, is that its not exactly direct. Meaning its not about counting heads in a group. It can’t be when researchers want to study large populations. When trying to assess something on a country-wide level, it means making estimates about larger numbers, often using models to generalize information to a greater level. While this is necessary, it can create questions of effectiveness in specific situations. In this case, the investigators created a “novel penalized synthetic control method.” They describe it as such: “This method estimates an average treatment effect from a longitudinal dataset on multiple treated and control individuals. We create a synthetic counterpart of each treated and control unit by closely matching on the target unit’s and their groups’ average pre-treatment outcome history using the pooled synthetic 27 control strategy. Further, we use a novel penalty so that the resulting estimators are adaptive to the latent groups in the data whose members have similar quarterly non-payment patterns.” They go on to explain it further, but the point in me quoting it, is to show it’s a bit more complicated than counting up the prescriptions or payments by themselves. So can there be error in models? Of course. Am I saying there is one here? Not exactly. I’m just pointing out a strange piece of data, which was spoken about only partially, and which works to ask more questions than it answers. Another reality to consider, is that researchers looked at payments from opioid manufacturers to physicians; something often looked at as a corrupt way to get more prescriptions written. The researchers in the study overlook this idea, and actually say “interactions between these manufacturers and physicians are critical to advance existing pain management protocols.” And that “Direct payments from opioid manufacturers to physicians are established conduits to facilitate such interactions.” In fact, the researchers seem concerned about less money flowing from opioid producers to doctors. They say, “The finding that the opioid manufacturers in states that passed MML are stepping away from this particular form of interaction is concerning, for such activity can significantly affect the opioids ecosystem.” ![]() Do we really want doctors taking payments from opioid manufacturers?!?The researchers in the study sound concerned about a possible erosion of the opioid market. But…isn’t that we want? Something like weed to affect the current opioid eco-system and lower the amount of use? And don’t we want to see less of them prescribed, and doctors paying less attention to opioid manufacturers? Perhaps the biggest issue with this study, beyond making an implication about legalized states uniformly prescribing more opioids vs non-opioids than non-legal states, is that it seems to be written by researchers who fully support payments made from opioid producers directly to the doctors who prescribe them. Which has already caused tons of controversy in that those who accept such payments, tend to write more prescriptions. This can be seen in an investigation into pharmaceutical payments directly to doctors in the state of New York. In this 2018 report by New York Health Foundation, it found that among other things, “Physicians who received payments from opioid manufacturers prescribed more opioids to Medicare patients than physicians who did not receive any opioid-related payments.” How much money are we talking about, and how frequently did it seem to have this effect? According to the report, “More than $3.5 million in opioid-related payments were made to physicians in New York State by pharmaceutical companies; about one in ten physicians who prescribed opioids to Medicare patients received a payment.” It said that, “Moreover, a higher number of opioid prescriptions was associated with more opioid-related payments to physicians.” However, it also found that these payments were concentrated among a choice few doctors, “Opioid-related payments from industry were concentrated within a small proportion of physicians, who tended to prescribe a large quantity of opioids. The top 1% of physicians in New York, in terms of the amount received in opioid-related payments, received more than 80% of total payments.” So perhaps the finding of the current report that less money is going to doctors from opioid producers, is actually an indication of a lessening of these seemingly corrupt payments, which have led to more prescribing. Which is technically what we want in this climate. And which therefore strongly calls into question the motives of the researchers and why this information makes them concerned. ![]() ConclusionI admit I’m slightly confused. The study talks about medical weed bringing down opioid use as seen through payments, which in the middle of a crisis like this, is optimal. Then it backhandedly turns this around and essentially questions if this is a good idea. Perhaps this study is an example of how research is often funded for a purpose, and not always with the best of intentions. I can’t say this for sure, as no funding information is given. Maybe a problem in and of itself. Hello readers. We appreciate you joining us at Cannadelics.com; a place for independent news reporting on the ever present world of drugs. Stop by regularly to keep in-the-loop on important stories, and sign up to the Cannadelics Weekly Newsletter, so you’re always on top of what’s going on. The post New Study On Payment Info Shows Weed Might Lower Opioid Use appeared first on Cannadelics. Via https://cannadelics.com/2023/05/01/new-study-on-payment-info-shows-weed-might-lower-opioid-use/ If you’re looking to experience the remarkable world of legal psychedelics, don’t miss out on our Deal of the Day promotion for Amanita Mushroom Caps. These Grade A Mushroom Caps, featuring the unique Amanita Muscaria and Amanita Pantherina species, offer a potent and distinct psychedelic experience for those seeking to explore the fascinating realm of psychedelics. Looking at the two mushrooms, Amanita Muscaria offers a more dissociative and dream-like experience compared to other psychedelics like psilocybin or LSD, while Amanita Pantherina is even more potent, boasting a higher concentration of Muscimol & Ibotenic Acid. And with the latest batch boasting an impressive 4.55 mg of Muscimol & Ibotenic Acid per gram for Amanita Muscaria and 7.5 mg per gram for Amanita Pantherina, these Amanita Mushroom Caps are truly a treasure to behold… And as an added bonus, you can get an extra 20% off when you use the Cannadelics coupon code at checkout. This is an opportunity you don’t want to miss, as it’s rare to find such high-quality Amanita Mushroom Caps at such an affordable price. So whether you’re an experienced psychonaut or a curious beginner, take advantage of our Deal of the Day promotion and get ready to embark on a journey into the captivating world of Amanita Mushroom Caps. Don’t miss out on this great opportunity to stock-up on Amanita Mushroom Caps, and enjoy a unique and potent psychedelic experience with these premium quality mushrooms. Click here to Buy Amanita Mushroom Caps (With Cannadelics coupon code) Amanita Muscaria and Pantherina: Unleash the Power of Amanita Mushroom CapsAmanita Mushroom Caps offer a unique and potent psychedelic experience for those seeking to explore the world of legal psychedelics. Featuring two remarkable species – Amanita Muscaria and Amanita Pantherina, these Grade A Mushrooms are also known as “Raw Fruit” and are highly prized for their rich history of use in spiritual and shamanic practices across different cultures and regions of the world. Currently, as part of our Deal of the Day, both mushrooms are offered with an extra 20% discount using the Cannadelics coupon code! The Effects of Amanita Mushroom CapsAmanita Mushroom Caps deliver a distinctive psychedelic experience that differs from other more traditional substances like psilocybin or LSD. The effects of Amanita Muscaria tend to be more dissociative and dream-like, with less vivid visual hallucinations. On the other hand, Amanita Pantherina offers an even more potent experience, boasting a higher concentration of Muscimol & Ibotenic Acid. It’s essential to start with a low dose and adjust according to your individual response to ensure a safe and enjoyable journey. Dosing and Onset DurationWhen consuming Amanita Mushroom Caps, it’s crucial to consider factors like body weight, sensitivity to psychedelics, and previous experiences to determine the appropriate dose. A typical dose of Amanita Muscaria ranges between 5 to 10 grams of dried caps, whereas Amanita Pantherina may require a smaller dose due to its higher potency (however, in case you are new to Muscimol, please take a smaller dose and make sure to prepare your mushrooms well). The onset of effects can vary between 30 minutes to 2 hours after ingestion and may last anywhere from 4 to 10 hours, depending on the dose and individual factors. Storage and SafetyTo ensure the longevity and potency of your Amanita Mushroom Caps, store them in a cool, dark, and dry place, ideally in the original premium mylar bag provided. Always keep them out of reach of children and pets. If you have any pre-existing medical conditions or are taking medications, consult with a healthcare professional before consuming Amanita Mushroom Caps. Exercise caution and start with a low dose, especially if you’re new to psychedelics or trying a new species like Amanita Pantherina. The Various Usages of Amanita Mushroom CapsAmanita Mushrooms are not only used recreationally, but also for medicinal and spiritual purposes. Traditionally, these mushrooms have been used in shamanic and spiritual practices across various cultures. Some indigenous tribes have used these mushrooms for their medicinal properties, such as treating anxiety and depression. In recent years, Amanita Mushrooms have gained popularity as a tool for self-exploration and personal growth. Many people report profound insights and transformative experiences that have led to positive changes in their lives. Some people have also used these mushrooms for creative pursuits, as they report increased creativity and enhanced problem-solving abilities. Legal Status of Amanita Mushroom CapsWhile Amanita Muscaria and Amanita Pantherina are legal in many countries, it’s essential to check your local laws and regulations, as the legal status may vary depending on your location. In the United States, for example, Amanita Muscaria is legal, but Amanita Pantherina is classified as a controlled substance in some states. Always research the laws and regulations in your area before purchasing and consuming these mushrooms. Safety Tips and Responsible UseWhen embarking on a psychedelic journey with Amanita Mushroom Caps, it’s crucial to practice responsible use and adhere to the following safety tips:
Exploring More Amanita and Psychedelic ProductsThe world of Amanita mushrooms and other psychedelic substances is vast and filled with endless possibilities. As you expand your horizons, consider exploring other Amanita products, such as Amanita tinctures or extracts, which can offer a more controlled and precise dosing experience. Additionally, you may wish to delve into the realm of other psychoactive and psychedelic substances like psilocybin-containing mushrooms, LSD, or DMT, to further enhance your understanding and appreciation of the psychedelic experience. Takeaway Points:
In conclusion, Amanita Mushroom Caps, featuring the unique Amanita Muscaria and Amanita Pantherina species, offer a remarkable and potent psychedelic experience for those seeking to explore the fascinating world of legal psychedelics. Remember to start with a low dose, practice safety, and consult with a healthcare professional if needed. Embark on a journey like no other and delve into the captivating realm of Amanita Mushrooms. Don’t miss out on the Deal of the Day for Amanita Mushroom Caps, and get an extra 20% off with the Cannadelics coupon code! Click here to Buy Amanita Mushroom Caps (With Cannadelics coupon code) Join the Cannadelics Sunday EditionTo stay informed about the latest news, exclusive deals, and premium products in the world of cannabis and psychedelics, consider joining our weekly newsletter, theCannadelics Sunday Edition. Delivered every Sunday at 11 am EST, our newsletter offers a curated selection of the best stories of the week and exclusive discounts on premium cannabis and psychedelic products, including Amanita Mushroom Caps. By subscribing to the Cannadelics Sunday Edition, you’ll also become part of a growing community of like-minded individuals interested in the fascinating realm of psychedelic substances. Share experiences, discuss new products, and connect with others who share your passion for exploration and self-discovery. Together, we can learn, grow, and support one another on our unique journeys. Simply put your email below: Want to learn more about legal psychedelic products?
|
ABOUT MEHallo, ik ben Rosalina Klerkx, ik ben een RHIA-gecertificeerde zorgbeheerder met meer dan 6 jaar ervaring in het creëren van een productieve omgeving voor zorgprofessionals. Leiding gegeven aan een team van 12 opname- en verkoopmedewerkers in een instelling voor langdurige zorg met meer dan 170 patiënten. Opstellen van complexe HIPAA-conforme rapporten aan patiëntendienstcoördinatoren in een zorgkliniek. Archives
April 2023
Categories |